Search Results 1291-1300 of 17554 for Keloid
Imiquimod may stimulate the immune system. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.
About this study. This randomized phase II trial is for medically inoperable early stage non-small cell lung cancer (NSCLC) patients.
Mayo Clinic Radio: Chronic obstructive pulmonary disease (COPD) featured image · November is C. · Rose geranium oil may ease common painful nasal symptoms linked ...
Mayo Clinic surgeons have found that an innovative approach can help patients with obesity get lifesaving care. Obesity can be a barrier to liver transplant. Dr ...
Learn about the symptoms, causes and prevention of this cancer that starts in the rectum. Treatments include surgery, radiation therapy and chemotherapy.
The purpose of this randomized clinical trial is to test the efficacy of dexmedetomidine for the self-management of sedative therapy (SMST) in a sample of ...
Long COVID and the digestive system: Mayo Clinic expert describes common symptoms featured image · COVID-19 vaccines approved for use in infants through toddlers ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Learn more about the causes, symptoms, complications, treatment and self-care tips for this blotchy skin condition that affects the genital and anal areas.
Forty-eight international experts on membranous nephropathy have co-authored a consensus report that calls for a new method of classifying diagnoses of the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.